Adele Tulone
Palermo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
PNPLA3 polymorphisms and risk of hepatic and extrahepatic outcomes in MASLD: A meta-analysis of observational studies.
Journal: JHEP reports : innovation in hepatology
Published: March 07, 2026
One-Year Changes in Liver Stiffness Measurement, but Not in Alanine Aminotransferase and Controlled Attenuation Parameter, Predict Long-Term Liver Outcomes in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 15, 2025
ONE-YEAR CHANGES IN LSM, BUT NOT IN ALT AND CAP, PREDICT LONG-TERM LIVER OUTCOMES IN PATIENTS WITH MASLD.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 15, 2025
The ANTICIPATE-NASH Models Stratify Better the Risk of Clinical Events Than Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients With Advanced Chronic Liver Disease.
Journal: Gastroenterology
Published: April 24, 2025
Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis.
Journal: The lancet. Gastroenterology & hepatology
Published: March 26, 2025
A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta-Analysis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 13, 2024
Impact of first and further decompensation in patients with compensated ACLD due to MASLD.
Journal: Journal of hepatology
Published: July 18, 2024
Are we ready for genetic testing in metabolic dysfunction-associated steatotic liver disease?
Journal: United European gastroenterology journal
Published: November 03, 2023
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria.
Journal: Hepatology (Baltimore, Md.)
Published: June 19, 2023
Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 07, 2023
MAFLD: a multisystem disease.
Journal: Therapeutic advances in endocrinology and metabolism
Published: August 01, 2022
Last Updated: 09/26/2026